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Abstract
Aims/hypothesis We examined the hypothesis that elevation in urinary albumin creatinine ratio (ACR) in adolescents with type 1
diabetes is associated with abnormal retinal vascular geometry (RVG) phenotypes.
Methods A cross-sectional study at baseline of the relationship between ACR within the normoalbuminuric range and RVG in
963 adolescents aged 14.4 ± 1.6 years with type 1 diabetes (median duration 6.5 years) screened for participation in AdDIT. A
validated algorithm was used to categorise log10 ACR into tertiles: upper tertile ACR was defined as ‘high-risk’ for future
albuminuria and the lower two tertiles were deemed ‘low-risk’. RVG analysis, using a semi-automated computer program,
determined retinal vascular calibres (standard and extended zones) and tortuosity. RVG measures were analysed continuously
and categorically (in quintiles: Q1–Q5) for associations with log10 ACR and ACR risk groups.
Results Greater log10 ACR was associated with narrower vessel calibres and greater tortuosity. The high-risk group was more
likely to have extended zone vessel calibres in the lowest quintile (arteriolar Q1 vs Q2–Q5: OR 1.67 [95% CI 1.17, 2.38] and
venular OR 1.39 [0.98, 1.99]) and tortuosity in the highest quintile (Q5 vsQ1–Q4: arteriolar OR 2.05 [1.44, 2.92] and venular OR
2.38 [1.67, 3.40]). The effects of retinal vascular calibres and tortuosity were additive such that the participants with the narrowest
and most tortuous vessels were more likely to be in the high-risk group (OR 3.32 [1.84, 5.96]). These effects were independent of
duration, blood pressure, BMI and blood glucose control.
A list of AdDIT investigators is included in the Appendix andmembers of
the Trial Steering Committee are listed in the Acknowledgements.
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Conclusions/interpretation Higher ACR in adolescents is associated with narrower and more tortuous retinal vessels. Therefore,
RVG phenotypes may serve to identify populations at high risk of diabetes complications during adolescence and well before
onset of clinical diabetes complications.
Keywords AdDIT . Adolescents . Diabetic retinopathy . Microvascular complications . Nephropathy . Retinal vascular
geometry . Type 1 diabetes
Abbreviations
ACE-I ACE inhibitor
ACR Albumin creatinine ratio
AdDIT Adolescent Type 1 Diabetes Cardio-Renal
Intervention Trial
CRAE Central retinal arteriolar equivalent
CRVE Central retinal venular equivalent
CTa Arteriolar curvature tortuosity
CTv Venular curvature tortuosity
DBP Diastolic blood pressure
exMWa Mean width of all measurable arterioles in
the extended zone
exMWv Mean width of all measurable venules in
the extended zone
IQR Interquartile range
ORPS Oxford Regional Prospective Study
RASS Renin Angiotensin System Study
RVG Retinal vascular geometry
SBP Systolic blood pressure
SDS Standard deviation score
Introduction
Despite significant advances in the management of type 1 di-
abetes, premature cardiovascular mortality has not been signif-
icantly ameliorated, with most of the increase in cardiovascular
risk explained by diabetic nephropathy [1]. An effective meth-
od of identifying individuals who will develop severe micro-
vascular complications, including diabetic nephropathy, re-
mains elusive. While urinary albumin excretion measurement,
a functional measure, remains the favoured method for identi-
fying and monitoring persons who develop diabetic nephrop-
athy, it is clear that not all individuals develop albuminuria or
proteinuria before progressing to end-stage renal disease [2–4].
Furthermore, persons diagnosed with diabetes during child-
hood may have well over a decade of diabetes duration before
transition to adult care. However, children and adolescents do
not typically receive treatment during this prolonged period, as
clinically overt complications are infrequent and hypertension
uncommon. Nonetheless, evidence suggests that growth and
puberty are critical periods that accelerate the systemic
endotheliopathy leading to microvascular complications [5, 6].
The retina offers a unique opportunity to visualise and
study the vasculature (especially the microvasculature)
in vivo. Previous retinal vascular geometry (RVG) studies
considered the proximal branches of central retinal vessels
only [7]. We recently demonstrated the adverse effect of
glycaemic burden on more peripheral retinal vessel calibres
in youth with type 1 diabetes [8] and postulate that the earliest
adverse phenotypes will be apparent in the peripheral retina.
In adult studies of cardiovascular disease, arteriolar narrowing
has been associated with higher blood pressure and greater
cardiovascular risk, while venular changes have been sepa-
rately associated with proteinuria.
Evidence suggests an inherent predisposition to the devel-
opment of diabetes micro- and macrovascular complications
in a proportion of the population [9, 10]. Identifying persons at
high risk at the earliest possible time may allow for a preven-
tive intervention strategy ideally during early life. There is,
however, a paucity of data in paediatric populations with type
1 diabetes prior to onset of clinical diabetes complications,
arguably a period when the greatest benefit from intervention
may be derived and complications prevented rather than ame-
liorated. The Adolescent Type 1 Diabetes Cardio-Renal
Intervention Trial (AdDIT; http://isrctn.com registration
number 91419926) is the first interventional study in a
group of normoalbuminuric adolescents with type 1 diabetes
determined to be at high risk of developing kidney disease
based on their urinary albumin creatinine ratio (ACR) [11].
In this study, we examine the cross-sectional associations at
baseline between urinary ACR and RVG measures in adoles-
cents with type 1 diabetes screened for participation in AdDIT.
We hypothesised that higher urinary ACR is associated with
an adverse RVG phenotype involving both arterioles and ve-
nules in the peripheral retina.
Methods
Study population A cross-sectional study was carried out at
baseline of a multinational cohort comprising 1041
normoalbuminuric adolescents with type 1 diabetes, screened
for eligibility to the AdDIT, with mean age 14.4 years, median
diabetes duration 6.5 years and HbA1c 69 mmol/mol (8.5%).
Data for the current study were collected at the study baseline
visit prior to, or within 6 months of, trial commencement. We
present the baseline data only. Treatment outcomes and
unmasking of treatment allocation are beyond the scope of
this paper. Briefly, in the multicentre trial across the UK,
Diabetologia (2018) 61:968–976 969
Australia and Canada, adolescents considered to be at ‘high-
risk’ of diabetic nephropathy were randomised to an ACE
inhibitor (ACE-I) and/or statin (HMG-CoA reductase
inhibitor) or placebo [12], while the ‘low-risk’ cohort was
followed as a natural history observational cohort.
This study conformed to the Declaration of Helsinki and
was approved by The Cambridge University Research Ethics
Committee and the local ethics committees of each participat-
ing centre. Written informed consent was obtained from the
parents and assent from all study participants.
Retinal photography and measurements Of the 1041 partici-
pants, 982 (94%) had full clinical data and standardised digital
two-field retinal photographs from both eyes taken at baseline
(central optic disc field and macula field). There were no clin-
ically or biochemically significant differences between those
with and without retinal photographs. We excluded those with
ungradable photographs due to either poor quality of retinal
photographs (n = 14, 1.4%) or for whom fewer than four of the
largest vessels could be traced by the computer-assisted pro-
gram in either eye (n = 5, 0.5%). Thus, 963 (92%) participants
were included in analyses for this report. RVG was assessed
using SIVA (Singapore I Vessel Assessment, Singapore,
Republic of Singapore), a semi-automated computer-assisted
image program. A single trained grader, masked to partici-
pants’ identities, applied the program to each retinal photo-
graph, to measure retinal microvascular geometric variables
within a concentric zone between the optic disc margin and
two optic disc diameters away from the optic disc margin. The
grader allowed the software to detect the centre of the optic
disc and divided the region into three subzones surrounding
the optic disc, zones A, B, C, corresponding to 0.5, 1.0 and 2.0
optic disc diameters away from the optic disc margin, respec-
tively (Fig. 1). Once the optic disc and the three concentric
subzones were appropriately located, the grader executed the
program to trace all vessels. The grader ensured that all arte-
rioles and venules were correctly identified. The software
combined the individual measurements into summary indices
of vessel calibres: the six largest vessels were used to calculate
the central retinal arteriolar equivalent (CRAE) and central
retinal venular equivalent (CRVE) in the standard zone B;
the mean width of all measurable arterioles in the extended
zone (exMWa) and mean width of all measurable venules in
the extended zone (exMWv) (out to zone C) were calculated
and arteriolar curvature tortuosity (CTa) and venular curvature
tortuosity (CTv) were calculated as measures of vessel
undulation, as previously described [13].
Renal function measures Centralised assessment of all urine
samples was performed at The WellChild laboratory at The
Evelina Children’s Hospital, London, UK. Samples were stored
at −70°C prior to shipping. Urine albumin was measured using
laser immunonephelometry (Siemens BN Prospec; Siemens
Healthcare, Erlangen, Germany) and, for concentrations
<2.1 mg/l, by an ELISA [11]. Urine creatinine was measured
using a chromatographic stable isotope dilution electrospray
MS–MS method. For each participant, the two time point
log10 ACR measures, each based on three consecutive early
morning samples at two separate visits, were averaged on the
log10 ACR scale and the average residual calculated using age,
sex and duration and the coefficients from the previously de-
scribed linear regression model in the Oxford Regional
Prospective Study (ORPS) cohort [14]. High-risk ACR was
defined as being in the highest tertile, within the
normoalbuminuric range, according to a standardised ACR that
predicted 85% of adolescents with type 1 diabetes who later
developedmicroalbuminuria and 100%who developed clinical
proteinuria in the ORPS [15]. The upper ACR tertile (high-risk
group) was assigned to residual value >1.2, the middle ACR
tertile to values of 0.8–1.2 and lower ACR tertile to values
<0.8. For this study, the lower two tertiles were combined for
analysis as the low-risk group [11].
The eGFR was calculated using the following formula:
eGFR (ml min−1 1.73 m−2) = 42 × height (cm) / plasma creat-
inine (μmol/l) [12]. Hyperfiltration was defined as eGFR
>135 ml min−1 1.73 m−2 [16].
Other variables HbA1c was analysed locally at each centre,
using DCCT aligned methods (HbA1c Variant analyser [Bio-
Rad Laboratories, Hercules, CA, USA], Adams Arkray
[Kyoto, Japan], Vantage analyser [Siemens Diagnostics,
Camberley, UK] or DCA 2000, [Siemens Diagnostics,
Tarrytown, NY, USA]). Lipid profile measurements (choles-
terol, HDL-cholesterol, LDL-cholesterol, triacylglycerol)
were measured using routine laboratory methods.
The standard deviation score (SDS) was calculated for
height, weight and BMI according to the least-mean squares
A B C
Standard zone
Extended zone
Fig. 1 Retinal photograph taken at baseline, showing central optic disc
field and macula field. Retinal zones according to SIVA: standard zone
(A+B), extended zone (A + B +C)
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method [17]. Blood pressure was measured using an Omran
M6 blood pressure monitor (Hoofddorp, the Netherlands)
and/or Dinamap monitor (Tampa, FL, USA) using an appro-
priate sized cuff. Age- and sex-related percentiles and SDS for
systolic blood pressure (SBP) and diastolic blood pressure
(DBP) were calculated according to published standards [18].
This study was approved by the Human Research Ethics
Committees of each participating centre. Informed consent
was obtained from participants and their families.
Statistics Descriptive data are summarised as mean ± SD for
parametric data and median (interquartile range [IQR]) for
non-parametric data. Urinary ACR was log10 transformed
for analysis and ACR groups were expressed as categorical
variables (high-risk [upper tertile] vs low-risk [the two lower
tertiles]). Thresholds were explored and quintiles deemed the
optimal category for analysis. RVG measures were analysed
as both continuous and categorical variables (quintiles). Mean
differences in retinal vascular measures between high-risk and
low-risk groups were determined using independent samples t
tests for normally distributed variables or Mann–Whitney U
tests for non-parametric variables. A χ2 test was used to com-
pare the likelihood of being in the high-risk ACR group de-
pending on retinal vascular measure quintiles.
Associations between log10 ACR, log10 eGFR and retinal
vascular measures as continuous variables were examined
using linear regression models. Binary logistic regression
was used to explore threshold effects of retinal vascular mea-
sures, arriving at quintiles as the optimal grouping as predic-
tors of high-risk and low-risk ACR groups. For vessel cali-
bres, Q2–Q5 were combined into a single category for analy-
sis. For tortuosity Q1–Q4, which were not statistically signif-
icantly different, were combined into a single category for
analysis. Univariable regression analyses were carried out
and multivariable regression models built using variables that
were significant in univariable analysis, including HbA1c,
BMI, SBP, lipids and duration. To test our proposed hypoth-
eses that both arteriolar and venular components of the micro-
vascular system contribute to the risk of microvascular dys-
function, we created two compound binary variables: (1)
exMWaQ1 & CTvQ5 (the lowest exMWa quintiles and
highest CTv quintile) and (2) exMWaQ1 & exMWvQ1 (the
lowest quintiles of exMWa and exMWv). All statistical anal-
yses were conducted using IBM SPSS version 22, Armonk,
NY, USA.
Results
Participant characteristicsCharacteristics of participants in the
high-risk and low-risk groups are shown in Table 1.
Adolescents in the high-risk group were younger, with shorter
diabetes duration, lower BMI, higher SBP SDS and higher
eGFR than those in the low-risk group. There were no signif-
icant differences in sex distribution, HbA1c or lipid profiles
between the two groups. Participants in the high-risk ACR
group had narrower arteriolar and venular calibres in both
standard (CRAE, CRVE) and extended zones (exMWa,
exMWv) (Fig. 2) as well as more tortuous vessels (CTa and
CTv) compared with those in the low-risk group.
Linear regression In univariable analysis, log10 ACR was in-
versely associated with BMI SDS (β −0.024 [95%CI −0.038,
−0.009], p = 0.002) and diabetes duration (β −0.017 [95% CI
−0.021, −0.012], p < 0.001) but not with HbA1c (β 0.0004
[95% CI −0.0006, 0.0014], p = 0.5), SBP SDS (β 0.010
[95% CI −0.004, 0.024], p = 0.1) or cholesterol (β −0.009
[95% CI −0.027, 0.008], p = 0.3).
Log10 ACR was inversely associated with the calibres of
the six largest arterioles (CRAE) in extended zones (exMWa
and exMWv) but not the calibres of the six largest venules
(CRVE). The compound variables (exMWaQ1 & CTvQ5;
Table 1 Clinical characteristics and retinal vascular measures by
ACR risk group
Characteristic Low-risk
(n=517)
High-risk
(n=446)
p value
Male sex, n (%) 276 (53) 237 (53) 0.9
Age, years 14.5 ± 1.6 14.2 ± 1.6 0.001
Diabetes duration, years 7.4 (4.9–10.2) 5.4 (3.6–8.1) <0.001
Height, cm 165.0 ± 10.4 163.6 ± 10.6 0.049
Weight, kg 61.8 ± 13.6 58.4 ± 13.4 <0.001
BMI, kg/m2 21.9 (19.7–24.6) 20.9 (18.8–23.5) <0.001
BMI SDS 0.95 ± 1.00 0.72 ± 1.05 0.001
Waist, cm 76.0 ± 10.0 74.3 ± 9.2 0.01
Waist:height 0.46 ± 0.06 0.45 ± 0.05 0.07
SBP, mmHg 115.6 ± 11.3 116.5 ± 12.0 0.3
SBP SDS −0.14 ± 1.05 0.03 ± 1.13 0.02
DBP, mmHg 65.3 ± 8.1 66.1 ± 8.1 0.2
DBP SDS 0.90 ± 0.92 1.01 ± 0.93 0.1
Smoking, proportion (%) 5/522 (1.0) 3/399 (0.8) 0.6
HbA1c, mmol/mol 68 ± 14 69 ± 16 0.3
HbA1c, % 8.4 ± 1.3 8.5 ± 1.4 0.3
Cholesterol, mmol/l 4.40 ± 0.86 4.38 ± 0.84 0.7
eGFR, ml min−1 1.73 m−2 122 ± 21 129 ± 24 <0.001
RVG
CRAE, μm 154.2 ± 12.3 151.7 ± 12.3 0.002
CRVE, μm 217.8 ± 17.5 215.6 ± 17.7 0.045
exMWa, μm 77.6 ± 6.6 75.5 ± 6.6 <0.001
exMWv, μm 88.8 ± 7.4 87.0 ± 7.9 0.001
CTa ×106 96.1 ± 1.3 99.7 ± 1.4 0.035
CTv ×106 89.8 ± 1.2 93.7 ± 1.3 0.006
Data are presented as mean ± SD for parametric data, median (IQR) for
non-parametric data and n (%) or proportion (%) for discrete data
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exMWaQ1 & exMWvQ1) showed an additive effect on log10
ACR (Table 2).
In multivariable models for each RVG variable, log10 ACR
was associated with narrower arteriolar calibres across extend-
ed zones (exMWa) and greater arteriolar and venular tortuos-
ity (CTa and CTv). There was a similar trend for venular
calibres (exMWv) but this did not reach statistical signifi-
cance. The compound variable exMWaQ1 & CTvQ5
remained significant with an additive effect on log10 ACR.
The associations remained significant after adjusting for
BMI SDS and diabetes duration. The compound variable
exMWaQ1 & exMWvQ1 showed a similar trend but did not
reach statistical significance (Table 2).
Logistic regression In univariable analysis, high-risk ACRwas
associated with shorter diabetes duration (OR 0.87 [95% CI
0.84, 0.91], p < 0.001), younger age (OR 0.87 [95% CI 0.80,
0.94], p = 0.001), lower BMI SDS (OR 0.80 [95% CI 0.70,
0.91], p = 0.001) and higher SBP SDS (OR 1.14 [95% CI
1.01, 1.29], p < 0.001), while its association with HbA1c
(OR 1.005 [95% CI 0.996, 1.014], p = 0.2) was not
significant.
In multivariable analysis, high-risk ACR was associated
with the lowest quintile for calibres in the extended zone
(exMWa and exMWv, Q1 vs Q2–Q5) and the highest quintile
for vessel tortuosity (CTa and CTv, Q5 vs Q1–Q4). The com-
pound variables (exMWaQ1 & CTvQ5; exMWaQ1 &
exMWvQ1) showed an additive effect for high-risk ACR
(Table 2). These findings remained significant after adjusting
for BMI SDS, duration and blood pressure SDS.
eGFRwas not significantly associated with RVG variables,
either continuously or categorically. No associations were
found between hyperfiltration and RVG.
Discussion
In this study we demonstrate that higher urinary ACR in ado-
lescents with type 1 diabetes is associated with a specific RVG
phenotype even before onset of clinical complications. Higher
ACRwas associated with narrower retinal vascular calibres and
increased vessel tortuosity even within the normoalbuminuric
range.
Our study adds significant new knowledge to this field.
First, we provide detailed and extensive analysis over a wider
area of the retina (extended zone), measuring not only vessel
calibres but also vessel tortuosity. Second, we report that ex-
tended zone calibres, both arteriolar and venular (exMWa and
exMWv, respectively) rather than CRAE and CRVE, were
more robust predictors of log10 ACR. Narrower retinal arteri-
oles (CRAE) in the standard zone have previously been asso-
ciated with vascular dysfunction and adverse cardiovascular
events [19–21]; here, we describe a novel association with
vessel calibres in the extended zone. In our study, participants
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RVG measures by ACR risk
groups. Retinal arteriolar calibre
in the extended zone was
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group than in the low-risk group.
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with the narrowest retinal calibres in the extended zone were
twice as likely to be in the high-risk ACR group. This pattern
suggests that inappropriate microvascular vasoconstriction oc-
curs in the high-risk ACR group, compounding the
neuroretinal ischaemia and pro-inflammatory state present in
the diabetes milieu early in the disease process. Since the
microvasculature provides the greatest contribution to system-
ic vascular resistance, we postulate that persistent inappropri-
ate arteriolar vasoconstriction will in due course result in sys-
temic blood pressure elevation [21] contributing to shear-
stress on the vessel wall and accelerating microvascular pa-
thology. This is in keeping with our observation that the high-
risk group had higher SBP SDS, albeit within the normal
range. Narrower venules in the setting of inadequate perfusion
are also likely to represent dysfunctional autoregulation,
which together with higher systemic blood pressure may in-
crease hydrostatic vessel damage. There are clear mechanistic
prospects such as hyperglycaemia leading to a downregulation
of Ca2+-activated K+ (BK) channels that are important in va-
sodilatation [22]. Such riskmay bemediated through inherited
individual differences in sensitivity and response to similar
glycaemic exposure [23].
We also demonstrate that greater tortuosity was associated
with higher log10 ACR. Notably, the highest quintile of
venular tortuosity was associated with greatest probability of
being in the high-risk ACR group. We previously demonstrat-
ed that greater tortuosity was associated with increased risk of
retinopathy [24] and renal dysfunction in our clinic population
[25, 26]. We now present the first multinational cohort
supporting these findings. We speculate that increased tortu-
osity may be the result of a maladaptive compensatory in-
crease in vessel density (or early neovascularisation), to im-
prove neuroretinal perfusion, in a predisposed population.
Third, we provide evidence supporting a unifying hae-
modynamic model integrating afferent (arteriolar) and ef-
ferent (venular) components of the microcirculation where-
by both components contribute to risk in an additive man-
ner. We report an adverse retinal phenotype comprising
narrower vessel calibres and greater tortuousity that was
associated with a significantly greater likelihood of a per-
son being in the high-risk ACR group than when either of
these measures were used alone.
We observed that individuals in the high-risk ACR group
were younger, had shorter diabetes duration and higher blood
Table 2 RVG measures are associated with urinary albumin excretion
RVG measure Linear regression: outcome log10 ACR Logistic regression: outcome high-risk ACR group
Univariable model Multivariable modela Univariate model Multivariable modelb
β (95% CI) p value β (95% CI) p value OR (95% CI) p value OR (95% CI) p value
RVG calibrec
CRAE (μm) −0.002 (−0.003, −0.001) 0.004 −0.001 (−0.002, 0.0003) 0.1 1.20 (0.89, 1.65) 0.3 1.04 (0.73, 1.49) 0.8
CRVE (μm) −0.001 (−0.001, 0.0003) 0.2 0.0001 (−0.001, 0.001) 0.8 1.27 (0.92, 1.74) 0.1 0.99 (0.70, 1.41) 0.95
exMWa (μm) −0.006 (−0.008, −0.003) <0.001 −0.004 (−0.006, −0.002) 0.001 1.96 (1.42, 2.71) <0.001 1.67 (1.17, 2.38) 0.005
exMWv (μm) −0.003 (−0.004, −0.001) 0.01 −0.001 (−0.003, 0.0008) 0.3 1.77 (1.29, 2.44) <0.001 1.39 (0.98, 1.99) 0.07
RVG tortuosityd
Loge CTa ×10
6 0.048 (−0.007, 0.103) 0.09 0.079 (0.02, 0.13) 0.005 1.78 (1.30, 2.46) <0.001 2.05 (1.44, 2.92) <0.001
Loge CTv ×10
6 0.067 (0.004, 0.13) 0.03 0.096 (0.03, 0.16) 0.003 2.15 (1.56, 2.98) <0.001 2.38 (1.67, 3.40) <0.001
Combined RVG models
exMWaQ1 &
CTvQ5 vs otherse
0.12 (0.06, 0.17) <0.001 0.11 (0.05, 0.17) <0.001 3.42 (1.96, 5.97) <0.001 3.32 (1.84, 5.96) <0.001
exMWaQ1 &
exMWvQ1 vs
othersf
0.08 (0.03, 0.13) 0.002 0.05 (−0.01, 0.10) 0.09 2.24 (1.43, 3.50) <0.001 1.77 (1.08, 2.90) 0.02
Each row represents a separate model. Outcome variable for linear regression modelling was log10 ACR. HbA1c, sex, lipids and SBP SDS were not
significant in univariable models. Outcome variable for logistic regression modelling was high-risk ACR group. HbA1c, sex and lipids were not
significant in univariable models
aMultivariable models are adjusted for BMI SDS and duration
bMultivariable models are adjusted for BMI SDS, duration and SBP SDS
c Logistic regression outcome is shown for Q1 vs Q2–Q5
d Logistic regression outcome is shown for Q5 vs Q1–Q4
e Logistic regression outcome is shown for exMWaQ1 & CTvQ5 vs the others
f Logistic regression outcome is shown for exMWaQ1 & exMWvQ1 vs the others
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pressure but no difference in glycaemic control compared with
the low-risk group. Thus, our data suggest the high-risk ACR
group, screened through ACR, may indeed be a population
predisposed to earlier onset of complications and likely to
benefit from earlier intervention. Current evidence supports
both genetic and metabolic mechanisms that protect against
and predispose to diabetes complications [9, 10, 27].
However, a clinically measurable and reproducible biomarker
associated with such risk has been elusive. The Renin
Angiotensin System Study (RASS), which examined young
adults with type 1 diabetes and normoalbuminuria, found that
central retinal vascular calibres were associated with histolog-
ical renal glomerular indices and their progression [7]. This
was observed despite there being no functional differences in
albumin excretion between the intervention (renin–angioten-
sin system blockade) and placebo groups, thus highlighting
the relevance of the retinal microvasculature as an early bio-
marker of diabetic nephropathy. Retinal vascular phenotypes
may reflect such genetic and metabolic predispositions and
thus may serve to identify persons at high risk of future com-
plications. In addition, retinal vascular phenotypes in the ex-
tended zones may be more responsive to intervention, includ-
ing ACE-I and statin therapy and more intensive glycaemic
control, early in the disease process.
The strengths of our study include the multinational collab-
oration and large sample size, standardised retinal photogra-
phy images and single-centre grading of retinal images
masked to clinical and biochemical participant data.
However, these are the baseline data and therefore cross-
sectional in nature. The longitudinal follow-up from AdDIT
will provide invaluable insights into the mechanisms of dia-
betes complications and potential benefits of early ‘pre-com-
plications’ intervention in paediatric cohorts. In addition to
their role as potential biomarkers for risk stratification of fu-
ture diabetes complications, RVG measures may provide an
opportunity to quantify the effect of intervention on the mi-
crovasculature in vivo. Furthermore, these RVG quantifica-
tion techniques may be applied to other previously conducted
interventional study cohorts such as RASS and the DCCT.
Long-term follow-up of such cohorts may determine the po-
tential to shift the current screening paradigm from one of
detection and treatment of diabetes complications to one of
identification of persons at risk and prevention of microvas-
cular complications.
In conclusion, we demonstrate that urinary ACR is associ-
ated with RVG variables prior to the onset of clinical compli-
cations in adolescents with type 1 diabetes. Higher ACR and
greater likelihood of being in the high-risk ACR group were
associated with narrower and more tortuous retinal vessels,
particularly in the extended zones. RVG may assist in identi-
fying individuals at high risk of complications early in the
disease process and may provide useful biomarkers by which
to quantify response to diabetes therapy.
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